不仅仅是甲基异噻唑啉酮:2017-2020年北美异噻唑啉酮过敏患者的回顾性分析
该回顾性横断面分析纳入9028例接受斑贴试验的患者,发现21.9%对至少一种异噻唑啉酮过敏,且异噻唑啉酮过敏患者更常见职业性皮肤病、原发性手部皮炎及年龄>40岁。仅测试MCI/MI会漏诊47.3%的MI过敏和60.1%的BIT过敏反应。
要点
- 21.9%(1976/9028)的患者对至少一种异噻唑啉酮斑贴试验阳性。
- 异噻唑啉酮过敏患者中44.1%(871/1976)对>1种异噻唑啉酮过敏。
- 仅测试MCI/MI会漏诊47.3%的MI过敏和60.1%的BIT过敏反应。
核心结论
- 异噻唑啉酮致敏率高,且对多种异噻唑啉酮过敏原的并发致敏常见。
研究设计与样本
- 回顾性横断面分析,纳入9028例接受甲基氯异噻唑啉酮(MCI)/甲基异噻唑啉酮(MI)0.02%水溶液、MI 0.2%水溶液、苯并异噻唑啉酮(BIT)0.1%凡士林和/或辛基异噻唑啉酮(OIT)0.025%凡士林斑贴试验的患者。
主要发现
- 21.9%(1976/9028)的患者对1种或多种异噻唑啉酮斑贴试验阳性。
- 与异噻唑啉酮非过敏(Is-)患者相比,异噻唑啉酮过敏(Is+)患者更可能有职业性皮肤病(16.5% vs 10.3%,P <.001)、原发性手部皮炎(30.2% vs 19.7%,P <.001)且年龄>40岁(73.1% vs 61.9%,P <.001)。
- 44.1%(871/1976)的Is+患者对>1种异噻唑啉酮斑贴试验阳性。
- 仅测试MCI/MI会漏诊47.3%(611/1292)的MI过敏和60.1%(466/776)的BIT过敏反应。
局限性
- 回顾性横断面研究设计且缺乏随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Isothiazolinones are a common cause of allergic contact dermatitis. OBJECTIVE: To examine the prevalence of positive patch test reactions to isothiazolinones from 2017-2020 and characterize isothiazolinone-allergic (Is+) patients compared with isothiazolinone nonallergic (Is-) patients. METHODS: Retrospective cross-sectional analysis of 9028 patients patch tested to methylchloroisothiazolinone (MCI)/methylisothiazolinone (MI) 0.02% aqueous, MI 0.2% aqueous, benzisothiazolinone (BIT) 0.1% petrolatum, and/or octylisothiazolinone (OIT) 0.025% petrolatum. Prevalence, reaction strength, concurrent reactions, clinical relevance, and source of allergens were tabulated. RESULTS: In total, 21.9% (1976/9028) of patients had a positive reaction to 1 or more isothiazolinones. Positivity to MI was 14.4% (1296/9012), MCI/MI was 10.0% (903/9017), BIT was 8.6% (777/9018), and OIT was 05% (49/9028). Compared with Is-, Is+ patients were more likely to have occupational skin disease (16.5% vs 10.3%, P <.001), primary hand dermatitis (30.2% vs 19.7%, P <.001), and be >40 years (73.1% vs 61.9%, P <.001). Positive patch test reactions to >1 isothiazolinone occurred in 44.1% (871/1976) of Is+ patients. Testing solely to MCI/MI would miss 47.3% (611/1292) of MI and 60.1% (466/776) of BIT allergic reactions. LIMITATIONS: Retrospective cross-sectional study design and lack of follow-up data. CONCLUSION: Sensitization to isothiazolinones is high and concurrent sensitization to multiple isothiazolinone allergens is common.
引用
- Reeder MJ, Zhang D, Aravamuthan SR, et al. More than just methylisothiazolinone: Retrospective analysis of patients with isothiazolinone allergy in North America, 2017-2020. J Am Acad Dermatol. 2023. PMID: 37879460. doi:10.1016/j.jaad.2023.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。